Search

Displaying results 3941 - 3950 of 10000 in total
  1. Drug

    Frovatriptan

    go.drugbank.com/drugs/DB00998
    Approved

    Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation.

  2. Drug

    Vonicog alfa

    go.drugbank.com/drugs/DB12872
    ApprovedInvestigational

    Vonicog alfa is a recombinant human von Willebrand factor (rVWF) produced from Chinese hamster ovary cells. Used to treat von Willebrand Disease (vWD), it mimics the biological actions of endogenous VWF, which is a critical plasma glycop...

  3. Drug

    RG2417

    go.drugbank.com/drugs/DB05055
    Investigational

    This new insight suggests that the symptoms of bipolar disorder may be linked to dysregulation of energy metabolism of the brain. … Uridine is synthesized by the mitochondria, the power plant of the human cell responsible for energy metabolism.

  4. Drug

    Indolidan

    go.drugbank.com/drugs/DB19499
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Indolidan is a cardiac stimulant, pimobendan derivative. Indolidan has a monoisotopic molecular weight of 257.12 Da.

  5. Drug

    Thyromedan

    go.drugbank.com/drugs/DB20438
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Thyromedan is a cardiac stimulant, pimobendan derivative. Thyromedan has a monoisotopic molecular weight of 734.88 Da.

  6. Drug

    Imazodan

    go.drugbank.com/drugs/DB20144
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Imazodan is a cardiac stimulant, pimobendan derivative. Imazodan has a monoisotopic molecular weight of 240.1 Da.

  7. Drug

    Prinoxodan

    go.drugbank.com/drugs/DB21318
    Experimental

    The usage of the INN stem '-dan' in the name indicates that Prinoxodan is a cardiac stimulant, pimobendan derivative. Prinoxodan has a monoisotopic molecular weight of 258.11 Da.

  8. Drug

    Nerandomilast

    go.drugbank.com/drugs/DB18237
    ApprovedInvestigational

    [L54126] On October 7, 2025, nerandomilast was approved as the first new treatment for idiopathic pulmonary fibrosis in more than a decade.

  9. Drug

    Rurioctocog alfa pegol

    go.drugbank.com/drugs/DB16007
    ApprovedInvestigational

    It was first approved by the European Commission in January 2018. … [A245149] Hemophilia A is the most common inherited bleeding disorder leading to deficiency of factor VIII, which is caused by defects in the F8C gene that encodes coagulation factor VIII.

  10. Drug

    Enprofylline

    go.drugbank.com/drugs/DB00824
    ApprovedWithdrawn

    Long-term enprofylline administration may be associated with elevation in liver enzyme levels and unpredictable blood levels.

    Synonyms: 3-n-propylxanthine